Cargando…

Multiple Beneficial Effects of Ghrelin Agonist, HM01 on Homeostasis Alterations in 6-Hydroxydopamine Model of Parkinson’s Disease in Male Rats

Background and objective: Developing therapy for non-motor symptoms of Parkinson’s disease (PD) is important for improving patients’ quality of life. Previously, we reported that the ghrelin receptor agonist, HM01 normalized the decreased 4-h fecal output and levodopa-inhibited gastric emptying in 6...

Descripción completa

Detalles Bibliográficos
Autores principales:	Minalyan, Artem, Gabrielyan, Lilit, Pietra, Claudio, Taché, Yvette, Wang, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474391/ https://www.ncbi.nlm.nih.gov/pubmed/31031602 http://dx.doi.org/10.3389/fnint.2019.00013

Ejemplares similares

Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors
por: Villars, Fabienne O., et al.
Publicado: (2017)

Acylated Ghrelin Receptor Agonist HM01 Decreases Lean Body and Muscle Mass, but Unacylated Ghrelin Protects against Redox-Dependent Sarcopenia
por: Ranjit, Rojina, et al.
Publicado: (2022)

Systemic Sclerosis: Current State and Survival After Lung Transplantation
por: Minalyan, Artem, et al.
Publicado: (2021)

Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Corrigendum: Anti-emetic Action of the Brain-Penetrating New Ghrelin Agonist, HM01, Alone and in Combination With the 5-HT(3) Antagonist, Palonosetron and With the NK(1) Antagonist, Netupitant, Against Cisplatin- and Motion-Induced Emesis in Suncus murinus (House Musk Shrew)
por: Rudd, John A., et al.
Publicado: (2018)

Ghrelin – A Pleiotropic Hormone Secreted from Endocrine X/A-Like Cells of the Stomach
por: Stengel, Andreas, et al.
Publicado: (2012)

Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications
por: Stengel, Andreas, et al.
Publicado: (2013)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Ghrelin alleviates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells
por: He, Xin, et al.
Publicado: (2021)

Peripheral α(2)-β(1) adrenergic interactions mediate the ghrelin response to brain urocortin 1 in rats
por: Yakabi, Koji, et al.
Publicado: (2014)

Ghrelin O-Acyl Transferase: Bridging Ghrelin and Energy Homeostasis
por: Shlimun, Andrew, et al.
Publicado: (2011)

Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model
por: Northrup, R., et al.
Publicado: (2013)

Structural basis of human ghrelin receptor signaling by ghrelin and the synthetic agonist ibutamoren
por: Liu, Heng, et al.
Publicado: (2021)

Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease
por: Galindo, Maria F., et al.
Publicado: (2012)

Parkinson’s Disease and the Heart: Studying Cardiac Metabolism in the 6-Hydroxydopamine Model
por: Silva da Fonsêca, Victor, et al.
Publicado: (2023)

Chlorogenic Acid Exerts Beneficial Effects in 6-Hydroxydopamine-Induced Neurotoxicity by Inhibition of Endoplasmic Reticulum Stress
por: Shan, Shihai, et al.
Publicado: (2019)

Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile
por: Pietra, Claudio, et al.
Publicado: (2014)

Lesioning of the Striatum Reverses Motor Asymmetry in the 6-Hydroxydopamine Rodent Model of Parkinsonism
por: Friehs, G. M., et al.
Publicado: (1991)

Upregulation of Cysteine Protease Cathepsin X in the 6-Hydroxydopamine Model of Parkinson’s Disease
por: Pišlar, Anja, et al.
Publicado: (2018)

Paeonol Protection Against Intrastriatal 6-Hydroxydopamine Rat Model of Parkinson’s Disease
por: Ghalami, Jamileh, et al.
Publicado: (2021)

Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
por: Stöger, Reinhard, et al.
Publicado: (2017)

Activin A Protects Midbrain Neurons in the 6-Hydroxydopamine Mouse Model of Parkinson’s Disease
por: Stayte, Sandy, et al.
Publicado: (2015)

Differences in brain pathological changes between rotenone and 6-hydroxydopamine Parkinson’s disease models
por: Liu, Lan-Xiang, et al.
Publicado: (2018)

Metabolomics and biochemical alterations caused by pleiotrophin in the 6-hydroxydopamine mouse model of Parkinson’s disease
por: Gramage, Esther, et al.
Publicado: (2022)

Intranasal delivery of mitochondria for treatment of Parkinson’s Disease model rats lesioned with 6-hydroxydopamine
por: Chang, Jui-Chih, et al.
Publicado: (2021)

Vasculature in the mouse colon and spatial relationships with the enteric nervous system, glia, and immune cells
por: Wang, Lixin, et al.
Publicado: (2023)

Evidence that central pathways that mediate defecation utilize ghrelin receptors but do not require endogenous ghrelin
por: Pustovit, Ruslan V, et al.
Publicado: (2017)

Effect of Ghrelin on Glucose-Insulin Homeostasis: Therapeutic Implications
por: Sangiao-Alvarellos, Susana, et al.
Publicado: (2010)

The Physiological Role of Ghrelin in the Regulation of Energy and Glucose Homeostasis
por: Sovetkina, Alina, et al.
Publicado: (2020)

Attenuation of Visceral and Somatic Nociception by Ghrelin Mimetics
por: N Mohammadi, Ehsan, et al.
Publicado: (2020)

Clinical utility of genomic profiling of AML using paraffin‐embedded bone marrow clots: HM‐SCREEN‐Japan 01
por: Hosono, Naoko, et al.
Publicado: (2023)

Novel properties of photofermentative biohydrogen production by purple bacteria Rhodobacter sphaeroides: effects of protonophores and inhibitors of responsible enzymes
por: Gabrielyan, Lilit, et al.
Publicado: (2015)

The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
por: Vegas‐Suárez, Sergio, et al.
Publicado: (2021)

H.M. the Emperor of Ethiopia
por: CERN PhotoLab
Publicado: (1967)

ST-HM: not only cranes
por: Bertone, C
Publicado: (2002)

ST-HM equipment consolidation
por: Rühl, I, et al.
Publicado: (2003)

Cognitive-Enhancing Effect of Quercetin in a Rat Model of Parkinson's Disease Induced by 6-Hydroxydopamine
por: Sriraksa, Napatr, et al.
Publicado: (2012)

Treadmill exercise alleviates short-term memory impairment in 6-hydroxydopamine-induced Parkinson’s rats
por: Cho, Han-Sam, et al.
Publicado: (2013)

Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson’s Disease
por: Haas, Stefan Jean-Pierre, et al.
Publicado: (2016)

Impaired Voluntary Wheel Running Behavior in the Unilateral 6-Hydroxydopamine Rat Model of Parkinson's Disease
por: Pan, Qi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bol5a12str330ug50ij3q5hcg9